Deardorf Caren 4/A
4/A · Crinetics Pharmaceuticals, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4/AAmended
Deardorf Caren
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-11+35,000→ 35,000 totalExercise: $19.30Exp: 2032-03-10→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]On March 14, 2022, the reporting person filed a Form 4 which inadvertently reported that she was granted an option to purchase 25,000 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person was granted an option to purchase 35,000 shares of common stock.
- [F2]The Option shall vest and become exercisable in three substantially equal annual installments on each of the first three anniversaries of the date of grant, subject to continued service as a director through each such vesting date.